Spinal muscular atrophy

Spinal muscular atrophy
ICD-10	I01.0, I09.2, I30.-I32.
ICD-9	420.90
DiseasesDB	9820
MedlinePlus	000182
eMedicine	med/1781  emerg/412
MeSH	muscular atrophy&field=entry#TreeC14.280.720 C14.280.720

Spinal Muscular Atrophy Microchapters
Home
Patient Info
Overview
Epidemiology and Demographics
Risk Factors
Screening
Other forms
Molecular Biology
Genetics
Types
Diagnosis
Diagnosis
Full Differential Diagnosis
Symptom
Physical Examination
Electrolyte & Biomarker Studies
Electrocardiogram
Chest X Ray
MRI and CT
Echocardiography or Ultrasound
Other Imaging Findings
Pathology
Other Diagnostic Studies
Treatment
Outcome measures
Therapeutics development
Indications For Surgery
Research
Pre-Operative Assessment
Post-Operative Assessment
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Spinal muscular atrophy Resources
Most recent articles on Spinal muscular atrophy
Most cited articles on Spinal muscular atrophy
Review articles on Spinal muscular atrophy
Review articles on Spinal muscular atrophy
CME Programs on Spinal muscular atrophy
Powerpoint slides on Spinal muscular atrophy
Images of Spinal muscular atrophy
Ongoing Trials on Spinal muscular atrophy at Clinical Trials.gov
US National Guidelines Clearinghouse on Spinal muscular atrophy
NICE Guidance on Spinal muscular atrophy
FDA on Spinal muscular atrophy
CDC on Spinal muscular atrophy
Spinal muscular atrophy in the news
Blogs on Spinal muscular atrophy</small>
Directions to Hospitals Treating Spinal muscular atrophy
Risk calculators and risk factors for Spinal muscular atrophy

For patient information click here

Editors-in-Chief: C. Michael Gibson, M.S., M.D.; Priyamvada Singh, MBBS

Synonyms and keywords: Werdnig-Hoffman, Intermediate SMA, Kugelberg-Welander

Treatment

Outcome measures|Therapeutics development

External links

• sma at NINDS
• SMA Support
• Spinal Muscular Atrophy - Fight SMA - An international nonprofit dedicated to finding a treatment or cure for spinal muscular atrophy. Visit Fight SMA's website and also the Spinal Muscular Atrophy Blog for the latest news and research information about the leading genetic killer of children under two.
• Families of Spinal Muscular Atrophy - An international nonprofit dedicated to advancing research and supporting individuals and families with sma. FSMA has a web site with news, information and message boards for individuals to post questions. FSMA is one of the largest US private funders of SMA research and has more than 30 chapters worldwide.FSMA
• SMA Trust - a UK registered charity working to fund medical research into Spinal Muscular Atrophy
• Jennifer Trust for Spinal Muscular Atrophy - A national charity in the UK dedicated both to supporting people affected by SMA, and investing in essential research into causes, treatments and eventually a cure for the condition

Cost Effectiveness of Spinal muscular atrophy

| group5 = Clinical Trials Involving Spinal muscular atrophy | list5 = Ongoing Trials on Spinal muscular atrophy at Clinical Trials.gov • Trial results on Spinal muscular atrophy • Clinical Trials on Spinal muscular atrophy at Google

| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Spinal muscular atrophy | list6 = US National Guidelines Clearinghouse on Spinal muscular atrophy • NICE Guidance on Spinal muscular atrophy • NHS PRODIGY Guidance • FDA on Spinal muscular atrophy • CDC on Spinal muscular atrophy

| group7 = Textbook Information on Spinal muscular atrophy | list7 = Books and Textbook Information on Spinal muscular atrophy

| group8 = Pharmacology Resources on Spinal muscular atrophy | list8 = AND (Dose)}} Dosing of Spinal muscular atrophy • AND (drug interactions)}} Drug interactions with Spinal muscular atrophy • AND (side effects)}} Side effects of Spinal muscular atrophy • AND (Allergy)}} Allergic reactions to Spinal muscular atrophy • AND (overdose)}} Overdose information on Spinal muscular atrophy • AND (carcinogenicity)}} Carcinogenicity information on Spinal muscular atrophy • AND (pregnancy)}} Spinal muscular atrophy in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Spinal muscular atrophy •

| group9 = Genetics, Pharmacogenomics, and Proteinomics of Spinal muscular atrophy | list9 = AND (pharmacogenomics)}} Genetics of Spinal muscular atrophy • AND (pharmacogenomics)}} Pharmacogenomics of Spinal muscular atrophy • AND (proteomics)}} Proteomics of Spinal muscular atrophy

| group10 = Newstories on Spinal muscular atrophy | list10 = Spinal muscular atrophy in the news • Be alerted to news on Spinal muscular atrophy • News trends on Spinal muscular atrophy</small>

| group11 = Commentary on Spinal muscular atrophy | list11 = Blogs on Spinal muscular atrophy

| group12 = Patient Resources on Spinal muscular atrophy | list12 = Patient resources on Spinal muscular atrophy • Discussion groups on Spinal muscular atrophy • Patient Handouts on Spinal muscular atrophy • Directions to Hospitals Treating Spinal muscular atrophy • Risk calculators and risk factors for Spinal muscular atrophy

| group13 = Healthcare Provider Resources on Spinal muscular atrophy | list13 = Symptoms of Spinal muscular atrophy • Causes & Risk Factors for Spinal muscular atrophy • Diagnostic studies for Spinal muscular atrophy • Treatment of Spinal muscular atrophy

| group14 = Continuing Medical Education (CME) Programs on Spinal muscular atrophy | list14 = CME Programs on Spinal muscular atrophy

| group15 = International Resources on Spinal muscular atrophy | list15 = Spinal muscular atrophy en Espanol • Spinal muscular atrophy en Francais

| group16 = Business Resources on Spinal muscular atrophy | list16 = Spinal muscular atrophy in the Marketplace • Patents on Spinal muscular atrophy

| group17 = Informatics Resources on Spinal muscular atrophy | list17 = List of terms related to Spinal muscular atrophy

}}Cateogry:Neurology